carvedilol has been researched along with Coronary Restenosis in 2 studies
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol is an antioxidant that inhibits smooth muscle cell proliferation and migration, whereas probucol is a vascular protectant and reduces stent restenosis by improving the lumen dimension at the stent placement site." | 5.33 | Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model. ( Ahn, YK; Cha, KS; Cho, JG; Hong, YJ; Hur, SH; Hyun, DW; Jeong, MH; Kang, JC; Kim, JH; Kim, KB; Kim, MH; Kim, W; Park, HW; Park, JC; Park, JT, 2005) |
| "Carvedilol is a direct inhibitor of vascular smooth muscle cell migration and proliferation through inhibition of mitogen-activated protein kinase activity and regulation of cell cycle progression." | 2.71 | Comparison between a sustained administration of carvedilol versus atenolol to reduce restenosis after coronary stenting. ( Cha, KS; Kim, DI; Kim, DS; Kim, HJ; Kim, JS; Kim, JW; Kim, MH, 2004) |
| "Carvedilol is an antioxidant that inhibits smooth muscle cell proliferation and migration, whereas probucol is a vascular protectant and reduces stent restenosis by improving the lumen dimension at the stent placement site." | 1.33 | Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model. ( Ahn, YK; Cha, KS; Cho, JG; Hong, YJ; Hur, SH; Hyun, DW; Jeong, MH; Kang, JC; Kim, JH; Kim, KB; Kim, MH; Kim, W; Park, HW; Park, JC; Park, JT, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, KS | 2 |
| Kim, MH | 2 |
| Kim, JW | 1 |
| Kim, DI | 1 |
| Kim, HJ | 1 |
| Kim, DS | 1 |
| Kim, JS | 1 |
| Kim, W | 1 |
| Jeong, MH | 1 |
| Hyun, DW | 1 |
| Hur, SH | 1 |
| Kim, KB | 1 |
| Hong, YJ | 1 |
| Park, HW | 1 |
| Kim, JH | 1 |
| Ahn, YK | 1 |
| Cho, JG | 1 |
| Park, JT | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
1 trial available for carvedilol and Coronary Restenosis
| Article | Year |
|---|---|
Comparison between a sustained administration of carvedilol versus atenolol to reduce restenosis after coronary stenting.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Atenolol; C | 2004 |
1 other study available for carvedilol and Coronary Restenosis
| Article | Year |
|---|---|
Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model.
Topics: Animals; Antioxidants; Carbazoles; Carvedilol; Coronary Restenosis; Disease Models, Animal; Probucol | 2005 |